Radionuclide Therapy of Bone Metastases

2012 ◽  
pp. 85-100
Author(s):  
Alain S. Abi-Ghanem ◽  
Katherine Zukotynski
2015 ◽  
Vol 42 (6Part21) ◽  
pp. 3471-3471
Author(s):  
N Benabdallah ◽  
M Bernardini ◽  
A Desbree ◽  
C de Labriolle-Vaylet ◽  
D Franck

2021 ◽  
Vol 66 (1) ◽  
pp. 79-84
Author(s):  
I Pimonova ◽  
V. Krylov ◽  
P Isaev ◽  
T. Kochetova ◽  
E Borodavina

The article reviews domestic and foreign literature on the use of radiation therapy in the treatment of medullary thyroid cancer. The possibilities of various radiation methods in the treatment of patients with distant metastases are shown. In addition to classical types of remote irradiation, data are presented on the possibilities of radionuclide therapy (peptide-receptor therapy with somatostatin analogs and radionuclide therapy with osteotropic drugs for bone metastases). Methods of combined therapy with the use of osteomodifying agents, targeted drugs and other methods are described, which make it possible to increase the effectiveness of treatment of patients with medullary thyroid cancer with bone metastases.


2012 ◽  
Vol 33 (7) ◽  
pp. 726-732 ◽  
Author(s):  
Cecilia Hindorf ◽  
Sarah Chittenden ◽  
Anne-Kirsti Aksnes ◽  
Chris Parker ◽  
Glenn D. Flux

Sign in / Sign up

Export Citation Format

Share Document